These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28443521)

  • 21. Anticancer activities of some newly synthesized pyrazole and pyrimidine derivatives.
    Mohamed AM; El-Sayed WA; Alsharari MA; Al-Qalawi HR; Germoush MO
    Arch Pharm Res; 2013 Sep; 36(9):1055-65. PubMed ID: 23737106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, cytotoxicity and molecular modeling studies of some novel fluorinated pyrazole-based heterocycles as anticancer and apoptosis-inducing agents.
    Fayed EA; Eissa SI; Bayoumi AH; Gohar NA; Mehany ABM; Ammar YA
    Mol Divers; 2019 Feb; 23(1):165-181. PubMed ID: 30099687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combretastatin A-4 analogues with benzoxazolone scaffold: Synthesis, structure and biological activity.
    Gerova MS; Stateva SR; Radonova EM; Kalenderska RB; Rusew RI; Nikolova RP; Chanev CD; Shivachev BL; Apostolova MD; Petrov OI
    Eur J Med Chem; 2016 Sep; 120():121-33. PubMed ID: 27187864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Wang J; Tang Q; Wu C; Zhao Y; Zheng P
    Bioorg Med Chem; 2016 Apr; 24(8):1749-56. PubMed ID: 26964675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of isoerianin analogues as promising anticancer agents.
    Messaoudi S; Hamze A; Provot O; Tréguier B; Rodrigo De Losada J; Bignon J; Liu JM; Wdzieczak-Bakala J; Thoret S; Dubois J; Brion JD; Alami M
    ChemMedChem; 2011 Mar; 6(3):488-97. PubMed ID: 21360820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
    Yuan L; Song C; Li C; Li Y; Dong L; Yin S
    Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
    Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
    Eissa IH; El-Naggar AM; El-Hashash MA
    Bioorg Chem; 2016 Aug; 67():43-56. PubMed ID: 27253830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
    Kumar D; Jain SK
    Curr Med Chem; 2016; 23(38):4338-4394. PubMed ID: 27516198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a six-membered fused N-heterocyclic ring via a new 3-component reaction: synthesis of (pyrazolo)pyrimidines/pyridines.
    Kumar PM; Kumar KS; Mohakhud PK; Mukkanti K; Kapavarapu R; Parsa KV; Pal M
    Chem Commun (Camb); 2012 Jan; 48(3):431-3. PubMed ID: 22075973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
    Abdel-Aziz HA; Saleh TS; El-Zahabi HS
    Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
    El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
    Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents.
    Prachayasittikul S; Pingaew R; Worachartcheewan A; Sinthupoom N; Prachayasittikul V; Ruchirawat S; Prachayasittikul V
    Mini Rev Med Chem; 2017; 17(10):869-901. PubMed ID: 27670581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, anticancer activity and molecular docking of new triazolo[4,5-
    Khattab RR; Hassan AA; A Osman DA; Abdel-Megeid FM; Awad HM; Nossier ES; El-Sayed WA
    Nucleosides Nucleotides Nucleic Acids; 2021; 40(11):1090-1113. PubMed ID: 34496727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrazoles and Fused Pyrimidines: Synthesis, Structure Elucidation, Antitubercular Activity and Molecular Docking Study.
    Al-Soliemy AM; Sabour R; Farghaly TA
    Med Chem; 2022; 18(2):181-198. PubMed ID: 33761862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents.
    Naresh Kumar R; Poornachandra Y; Nagender P; Mallareddy G; Ravi Kumar N; Ranjithreddy P; Ganesh Kumar C; Narsaiah B
    Eur J Med Chem; 2016 Jan; 108():68-78. PubMed ID: 26629861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
    Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
    Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-Substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, antitumor and EGFR tyrosine kinase inhibitory activity.
    Abbas SE; Aly EI; Awadallah FM; Mahmoud WR
    Chem Biol Drug Des; 2015 May; 85(5):608-22. PubMed ID: 25318985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A convenient synthesis and molecular modeling study of novel pyrazolo[3,4-d]pyrimidine and pyrazole derivatives as anti-tumor agents.
    Nassar IF; Atta-Allah SR; Elgazwy AS
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):396-405. PubMed ID: 25068728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.